BEDFORD, Mass. (AP) _ Ocular Therapeutix Inc. (OCUL) on Friday reported a loss of $17.1 million in its first quarter.
The Bedford, Massachusetts-based company said it had a loss of 45 cents per share.
The biotechnology company posted revenue of $492,000 in the period, topping Street forecasts. Three analysts surveyed by Zacks expected $446,000.
The company's shares closed at $3.66. A year ago, they were trading at $6.73.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCUL at https://www.zacks.com/ap/OCUL